Results 31 to 40 of about 4,447 (297)

La Pasionaria en el teatro de Ignacio Amestoy y Salvador Távora

open access: yesL'Âge d'or, 2020
En 1993, Ignacio Amestoy crée avec Teatro Gasteiz et Salvador Távora Pasionaria ¡No pasarán!, pièce qui théâtralise la figure mythique de Dolores Ibárruri comme Vierge douloureuse qui va chercher le corps de son fils mort, Rubén, à Stalingrad pour le ...
Claire Dutoya
doaj   +1 more source

Death and the Screen [Special Issue]

open access: yes, 2022
This wholly open access special issue of Revenant: Critical and Creative Studies of the Supernatural, guest edited with colleague Dr Renske Visser, includes interdisciplinary critical and creative submissions on myriad intersections between death and the
Visser, Renske, Michael-Fox, Bethan
core  

The Revenant. Un cheval au travail

open access: yes, 2022
International audienceThis article offers an analysis of the activity of a racehorse named The Revenant that we followed in training at the Blondeau School in 2017 as part of the ChevalEduc program.
Sophie Barreau   +5 more
core   +1 more source

Claudin‐6 Protein Expression in Atypical Teratoid/Rhabdoid Tumors Is Strongly Enriched in the Molecular Subgroup AT/RT‐TYR

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Claudin‐6 has emerged as a promising immunotherapeutic target, yet protein‐level data in atypical teratoid/rhabdoid tumors (AT/RTs) have been inconsistent. We analyzed 36 well‐characterized AT/RT samples and found membranous claudin‐6 protein expression in 58% of cases, with striking enrichment in the molecular subgroup AT/RT‐TYR (100%) and ...
Victoria E. Fincke   +4 more
wiley   +1 more source

Di nuovo schiave. Donne e distopia (2007-2022)

open access: yesNarrativa, 2022
Cet article propose une analyse des particularités et des récurrences de la fiction dystopique écrite par des femmes en Italie sur une période allant de 2007 à 2022.
Claudia Carmina
doaj   +1 more source

Time Toxicity in Wilms Tumor: Quantifying the Burden of Healthcare Interaction in the First Year After Diagnosis

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Wilms tumor (WT) treatment imposes a significant time burden on patients and their families. Time toxicity is a patient‐centered metric that quantifies the burden of healthcare interaction. We sought to define time toxicity in the first year after diagnosis of WT and hypothesized that it would increase as tumor stage and treatment ...
Caleb Q. Ashbrook   +6 more
wiley   +1 more source

Projevy nepietního způsobu ukládání mrtvých u středověkých populací

open access: yesAntropoWebzin, 2011
In this study is collected a number of existing pieces of knowledge about substandard treatment with the dead bodies. There are also discussed the reasons which led the society to these acts. These persons were the revenants (e.
Lucie Čulíková
doaj  

La peur du revenant au XVIe siècle

open access: yes, 1975
Jacque Jeannine. La peur du revenant au XVIe siècle. In: Espaces Temps, 1, 1975. pp.
Jacque, Jeannine
core   +1 more source

Emapalumab for Immune Effector Cell‐Associated Hemophagocytic Lymphohistiocytosis‐Like Syndrome Following CD19‐Directed CAR‐T in Two Patients With B‐ALL: Clinical and Biomarker Correlates

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Immune effector cell‐associated hemophagocytic lymphohistiocytosis‐like syndrome (IEC‐HS) is a life‐threatening hyperinflammatory toxicity distinct from cytokine release syndrome (CRS) and neurotoxicity following chimeric antigen receptor T‐cell (CAR‐T) therapy. In a single‐institution retrospective cohort of pediatric and young adult patients
Thomas J. Galletta   +6 more
wiley   +1 more source

Native American Women as Palimpsestic Apparitions in Alejandro Gonzales Iñárritu’s The Revenant

open access: yesEuropean Journal of American Studies, 2022
Alejandro Gonzales Iñárritu’s mythic retelling of the Hugh Glass story revises and critiques the grand narratives of American exceptionalism born of the frontier.
M. Elise Marubbio
doaj   +1 more source

Home - About - Disclaimer - Privacy